Search Results - "Tambone, Sara"

Baricitinib: therapeutic potential for moderate to severe atopic dermatitis by Calabrese, Laura, Malvaso, Dalma, Chiricozzi, Andrea, Tambone, Sara, D'Urso, Dario Francesco, Guerriero, Cristina, Peris, Ketty

“…Atopic dermatitis (AD) is a chronic inflammatory skin disease mediated by multiple signals including janus kinase (JAK)/signal transducer and activator of…”
Get more information

HAP40 is a conserved central regulator of Huntingtin and a potential modulator of Huntington's disease pathogenesis by Xu, Shiyu, Li, Gang, Ye, Xin, Chen, Dongsheng, Chen, Zhihua, Xu, Zhen, Daniele, Moretti, Tambone, Sara, Ceccacci, Alessandra, Tomei, Licia, Ye, Lili, Yu, Yue, Solbach, Amanda, Farmer, Stephen M, Stimming, Erin Furr, McAllister, George, Marchionini, Deanna M, Zhang, Sheng

“…Perturbation of huntingtin (HTT)'s physiological function is one postulated pathogenic factor in Huntington's disease (HD). However, little is known how HTT is…”
Get full text

Satisfaction and attitudes toward systemic treatments for psoriasis: A cross‐sectional study by Esposito, Maria, Giunta, Alessandro, Gisondi, Paolo, Tambone, Sara, Rovaris, Marco, Manfreda, Valeria, Pirro, Federico, Pellegrini, Cristina, Fargnoli, Maria Concetta, Bianchi, Luca, Peris, Ketty, Girolomoni, Giampiero

“…In psoriasis patients, satisfaction and patients' attitude toward treatment are heterogeneous depending on several factors and remain poorly investigated,…”
Get full text

Lived experience of ethical challenges among undergraduate nursing students during their clinical learning by Gonella, Silvia, Viottini, Elena, Gastmans, Chris, Tambone, Sara, Conti, Alessio, Campagna, Sara, Dimonte, Valerio

“…Undergraduate nursing students may experience several ethical challenges during their clinical learning placement that can lead to moral distress and intention…”
Get full text

NRF2 activation by reversible KEAP1 binding induces the antioxidant response in primary neurons and astrocytes of a Huntington's disease mouse model by Moretti, Daniele, Tambone, Sara, Cerretani, Mauro, Fezzardi, Paola, Missineo, Antonino, Sherman, Leticia-Toledo, Munoz-Sajuan, Ignacio, Harper, Steven, Dominquez, Celia, Pacifici, Robert, Tomei, Licia, Park, Larry, Bresciani, Alberto

“…Oxidative stress has been associated with pathogenesis in several diseases including Huntington's disease (HD), a neurodegenerative disorder caused by a…”
Get full text

Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation by Galluzzo, Marco, Talamonti, Marina, De Simone, Clara, D'Adamio, Simone, Moretta, Gaia, Tambone, Sara, Caldarola, Giacomo, Fargnoli, Maria Concetta, Peris, Ketty, Bianchi, Luca

“…To evaluate efficacy and safety of the anti-IL-17 drug secukinumab in a real-life large cohort of patients with moderate-to-severe plaque psoriasis in Central…”
Get more information

Long-term efficacy and safety of daylight photodynamic therapy with methyl aminolevulinate for actinic keratosis of the face and scalp by Fargnoli, Maria Concetta, Piccioni, Antonella, Neri, Luca, Tambone, Sara, Pellegrini, Cristina, Peris, Ketty

Get full text

The combination of oral and topical photoprotection with a standardized Polypodium leucotomos extract is beneficial against actinic keratosis by Pellacani, Giovanni, Peris, Ketty, Ciardo, Silvana, Pezzini, Claudia, Tambone, Sara, Farnetani, Francesca, Longo, Caterina, Chello, Camilla, González, Salvador

“…Introduction This study describes a prospective, multicentre, randomized controlled, open‐label study with three arms aimed at studying the differences…”
Get full text

The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies by Pirro, Federico, Caldarola, Giacomo, Chiricozzi, Andrea, Tambone, Sara, Mariani, Marco, Calabrese, Laura, D'Urso, Dario Francesco, De Simone, Clara, Peris, Ketty

“…The beginning of 2020 has been marked by COVID-19 pandemic, with a strong impact on several national health systems worldwide. To describe the impact of…”
Get full text

Optimization of linear and cyclic peptide inhibitors of KEAP1-NRF2 protein-protein interaction by Colarusso, Stefania, De Simone, Daniele, Frattarelli, Tommaso, Andreini, Matteo, Cerretani, Mauro, Missineo, Antonino, Moretti, Daniele, Tambone, Sara, Kempf, Georg, Augustin, Martin, Steinbacher, Stefan, Munoz-Sanjuan, Ignacio, Park, Larry, Summa, Vincenzo, Tomei, Licia, Bresciani, Alberto, Dominguez, Celia, Toledo-Sherman, Leticia, Bianchi, Elisabetta

“…[Display omitted] Inhibition of KEAP1-NRF2 protein-protein interaction is considered a promising strategy to selectively and effectively activate NRF2, a…”
Get full text

HAP40 is a conserved central regulator of Huntingtin and a potential modulator of Huntington’s disease pathogenesis by Shiyu Xu, Gang Li, Xin Ye, Dongsheng Chen, Zhihua Chen, Zhen Xu, Moretti Daniele, Sara Tambone, Alessandra Ceccacci, Licia Tomei, Lili Ye, Yue Yu, Amanda Solbach, Stephen M. Farmer, Erin Furr Stimming, George McAllister, Deanna M. Marchionini, Sheng Zhang

“…Perturbation of huntingtin (HTT)’s physiological function is one postulated pathogenic factor in Huntington’s disease (HD). However, little is known how HTT is…”
Get full text

Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis by Carubbi, Francesco, Fidanza, Rosaria, Palmieri, Maria, Ventura, Alessandra, Tambone, Sara, Cipriani, Paola, Giacomelli, Roberto, Fargnoli, Maria Concetta

“…The aim of this observational study was to assess safety and efficacy of certolizumab pegol (CZP) in a real-life cohort of patients affected by psoriasis (PsO)…”
Get full text

Photodynamic therapy with 5‐aminolevulinate patch for the treatment of superficial basal cell carcinomas by De Luca, Erika Valentina, Tambone, Sara, Catapano, Silvia, Fossati, Barbara, Peris, Ketty

“…5‐Aminolevulinate (ALA) patches with red light (630‐nm light source and a total light dose of 37 J/cm2) is an effective treatment indicated by food and drug…”
Get full text

Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial by Gutiérrez García-Rodrigo, Carlota, Pellegrini, Cristina, Piccioni, Antonella, Tambone, Sara, Fargnoli, Maria Concetta

“…•No data on the efficacy of repeated treatments of MAL DL-PDT for AKs of the face and scalp is available.•We demonstrated that two-treatment schedule of MAL…”
Get full text

Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities by Spallone, Giulia, Sollena, Pietro, Ventura, Alessandra, Fargnoli, Maria C., Gutierrez, Carlota, Piccerillo, Alfredo, Tambone, Sara, Bianchi, Luca, Peris, Ketty

“…Basal cell carcinoma (BCC) is the most common malignancy in Caucasians, and its incidence is increasing. Most BCCs are treated surgically, nevertheless surgery…”
Get full text

Cohort analysis of safety and efficacy of vismodegib in Italian patients from the Phase II, multicenter STEVIE study by Bossi, Paolo, Peris, Ketty, Calzavara-Pinton, Piergiacomo, Queirolo, Paola, Alfieri, Salvatore, Palla, Marco, Rossi, Maria Teresa, Spagnolo, Francesco, Tambone, Sara, Astolfi, Cinzia, Ascierto, Paolo A

“…To assess safety and efficacy of vismodegib in the Italian cohort from the SafeTy Events in VIsmodEgib study. Data from Italian patients with locally advanced…”
Get full text

HLA-C06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study by Talamonti, Marina, Galluzzo, Marco, Zangrilli, Arianna, Papoutsaki, Marina, Egan, Colin Gerard, Bavetta, Mauro, Tambone, Sara, Fargnoli, Maria Concetta, Bianchi, Luca

“…Background The genetic basis of predisposition to psoriasis is recognised; however, the response to psoriasis treatment in patients with different genetic…”
Get full text

Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp by Fargnoli, Maria Concetta, Piccioni, Antonella, Neri, Luca, Tambone, Sara, Pellegrini, Cristina, Peris, Ketty

Get full text

Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series by Tambone, Sara, Fargnoli, Maria C, Capizzi, Rodolfo, Peris, Ketty

“…In clinical studies, imiquimod 3.75% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or…”
Get more information

Real-life efficacy and safety of ingenol mebutate for the treatment of actinic keratosis of the face and scalp: A single arm retrospective study by Ricci, Francesco, Tambone, Sara, Neri, Luca, Fania, Luca, Piccioni, Antonella, Guerriero, Cristina, Fargnoli, Maria Concetta, Peris, Ketty

“…Background: The efficacy and safety of ingenol mebutate versus placebo have been proven in four randomized controlled trials (RCTs), although there is a lack…”
Get full text